Honorary doctorates awarded by Karolinska Institutet 2006

February 28, 2006

The Board of Research at Karolinska Institutet has awarded honorary doctorates of medicine to Robert G. Edwards, England; previous president of The Swedish Trade Union Confederation Bertil Jonsson, Sweden; and Dr. Philip Yeo, Singapore. The degrees are awarded to persons who have promoted by their actions activities carried out at the university. The conferment ceremony will take place in Stockholm City Hall on 12 May, 2006. This year marks the 100th anniversary of the first doctoral conferment ceremony at Karolinska Institutet, making this year's ceremony particularly noteworthy.

Robert G. Edwards, professor emeritus at the University of Cambridge is awarded the honorary degree of Doctor of Medicine. He is honoured for his major contributions to research in the field of infertility and in vitro fertilisation (IVF). IVF is considered to be one of the major medical discoveries of the 20th century, and it is without comparison the most successful treatment for infertility. Before the use of the IVF technique, only 30% of infertile couples could be helped. That fraction has today risen to 90%. Research into IVF has also made significant contributions to medical knowledge concerning fertility, and concerning early foetal development and diagnostic techniques.

Professor Edwards was born in Leeds, England, in 1925. He started his research career in the early 1950s, studying mouse embryonic chromosomes at the University of Edinburgh. He moved to Cambridge in the 1960s, where he developed a technique for fertilisation outside of the body. The first baby born with the aid of IVF was born in 1978, and the treatment spread rapidly throughout the world. It is estimated that more than 2 million longed-for children have been born with the use of IVF.

Bertil Jonsson, previous president of The Swedish Trade Union Confederation (LO-Sweden), is awarded the honorary degree of Doctor of Medicine. He is honoured for his long commitment to research concerning the workplace environment and health. Bertil Jonsson started his career as a sawmill worker with an interest in trade union issues. This brought him face-to-face with the fear of his workmates concerning the toxic chemicals that were used when working with newly sawn planks. He realised the need for improved protective equipment, regulations and knowledge concerning the workplace environment. His complete professional life has been characterised by work to prevent disease and accidents both at work and in the home. These were issues that Bertil Jonsson gave high priority not least during his time as president of LO-Sweden during the period 1993 2002.

Bertil Jonsson is 65 years old and has chaired the board of directors of Arbetsmarknadens försäkringsaktiebolag, AFA, since 2002. The AFA trust foundations for the support of research have provided significant contributions to the work of Karolinska Institutet. Research at KI supported by AFA has, for example, been an important component with respect to preventative measures concerning noise induced risks, and the incidence of back-problems and heavy lifting in working life.

Philip Yeo, chairman of A*STAR, the Singaporean Agency for Science, Technology and Research, is awarded the honorary degree of Doctor of Medicine. Philip Yeo has worked actively during the past 10 years to build medical research and education in Singapore, in collaboration with leading universities throughout the world, including Karolinska Institutet. Several collaborative agreements have been signed during these years between Karolinska Institutet and A* STAR, and between Karolinska Institutet and the National University of Singapore, concerning the exchange of researchers and students. Philip Yeo has played a critical part in ensuring that these agreements came about.

Philip Yeo was born in 1946 in Singapore. He received a doctorate in engineering from the University of Toronto and an MBA from Harvard University. During Philip Yeo's period as chairman of A*STAR, Singapore has developed to become a leading centre for biomedical research and development in Asia within fields such as the biological mechanisms of infection, functional genomics, and stem cell research.
-end-
For more information, please contact:

Dean of Research, Jan Carlstedt-Duke, telephone +46 8 5248 6470, mobile phone +46 70 792 4085, e-mail jan.carlstedt-duke@ki.se

Press Officer Katarina Sternudd, telephone +46 8 5248 3895, mobile phone +46 70 224 3895, e-mail katarina.sternudd@ki.se.

Karolinska Institutet

Related Medicine Articles from Brightsurf:

An ultrasonic projector for medicine
A chip-based technology that modulates intensive sound pressure profiles with high resolution opens up new possibilities for ultrasound therapy.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

How dinosaur research can help medicine
The intervertebral discs connect the vertebrae and give the spine its mobility.

Graduates of family medicine residencies are likely to enter and remain in family medicine
This study provides an overview of the characteristics of physicians who completed family medicine residency training from 1994 to 2017.

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Moving beyond 'defensive medicine'
Study shows removing liability concerns slightly increases C-section procedures during childbirth.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

Protein injections in medicine
One day, medical compounds could be introduced into cells with the help of bacterial toxins.

Study reveals complementary medicine use remains hidden to conventional medicine providers
Research reveals that 1 in 3 complementary medicine (CM) users do not disclose their CM use to their medical providers, posing significant direct and indirect risks of adverse effects and harm due to unsafe concurrent use of CM and conventional medicine use.

Study of traditional medicine finds high use in Sub-Saharan Africa despite modern medicine
Researchers who have undertaken the first systematic review of into the use of traditional, complementary and alternative medicines (TCAM) in Sub-Saharan Africa found its use is significant and not just because of a lack of resources or access to 'conventional medicine'.

Read More: Medicine News and Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.